Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT06382792

Osteolysis of Allograft Prosthetic Composite After Shoulder Resection for Tumors

Results of Proximal Humeral Reconstruction With Allograft Prosthetic Composite After Resection for Tumors

Status
Enrolling By Invitation
Phase
Study type
Observational
Enrollment
6 (estimated)
Sponsor
Central Hospital, Nancy, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The gold standard after shoulder resection for tumors is reconstruction by reverse prosthesis and allograft. This is an intervention also performed for more frequent etiologies (revisions of prosthesis, non cancerous humeral bone loss ...). The results in these etiologies are good, and do not find any particular mechanical complications (including no osteolysis of the graft). In the case of reconstruction for cancer, the numbers of patients are lower (rare pathologies) and some studies on small numbers found osteolysis of the allograft. The aim of this study is to analyze the presence or not osteolysis in these patients, and to quantify it precisely by scanner measurement (no data yet in the literature).

Detailed description

quantify bone stock of the allograft by scanner measurement in post operative and in 6 month to 1 years after surgery. This is a retrospective study, and the scanner was performed routinely every 3 to 6 month, during 2 years, for oncological follow up.

Conditions

Interventions

TypeNameDescription
PROCEDUREproximal humeral resection for tumor and allograft prosthetic composite reconstructionallograft prosthetic composite

Timeline

Start date
2024-05-01
Primary completion
2024-05-01
Completion
2024-05-01
First posted
2024-04-24
Last updated
2024-04-24

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06382792. Inclusion in this directory is not an endorsement.